Low-viscosity Hydroxypropyl Methylcellulose Research Articles

Surface Modification of Silk Fabric by Polysaccharide Derivatives towards High-Quality Printing Performance Using Bio-Based Gardenia Blue Ink.

Ink-jet-printed silk, a premium textile material, was achieved by utilizing a bio-based gardenia blue dye. However, the sharpness of the printing pattern is difficult to control due to the limited water-retention capacity of silk. To address this issue, three polysaccharide derivatives, namely, sodium alginate (SA), low-viscosity hydroxypropyl methyl cellulose (HPMC-I), and high-viscosity hydroxypropyl methyl cellulose (HPMC-II), were employed as thickeners to modify the silk by the dipping-padding method. Firstly, the preparation of the gardenia blue ink and the rheology assessment of the thickener solution were conducted. Furthermore, the impacts of different thickeners on the micro-morphology, element composition, and hydrophilicity of the silk, along with the wetting behavior of the ink on the silk, were analyzed comparatively in order to identify an appropriate thickener for preserving pattern outlines. Lastly, the color features, color fastness, and wearing characteristics of the printed silk were discussed to evaluate the overall printing quality. Research results showed that the optimized ink formulation, comprising 12% gardenia blue, 21% alcohols, and 5.5% surfactant, met the requirements for ink-jet printing (with a viscosity of 4.48 mPa·s, a surface tension of 34.12 mN/m, and a particle size of 153 nm). The HPMC-II solution exhibited prominent shear-thinning behavior, high elasticity, and thixotropy, facilitating the achievement of an even modification effect. The treatment of the silk with HPMC-II resulted in the most notable decrease in hydrophilicity. This can be attributed to the presence of filled gaps and a dense film on the fibers' surface after the HPMC-II treatment, as observed by scanning electron microscopy. Additionally, X-ray photoelectron spectroscopy analysis confirmed that the HPMC-II treatment introduced the highest content of hydrophobic groups on the fiber surface. The reduced hydrophilicity inhibited the excessive diffusion and penetration of gardenia blue ink, contributing to a distinct printing image and enhanced apparent color depth. Moreover, the printed silk demonstrated qualified color fastness to rubbing and soaping (exceeding grade four), a soft handle feeling, an ignorable strength loss (below 5%), and a favorable air/moisture penetrability. In general, the surface modification with the HPMC-II treatment has been proven as an effective strategy for upgrading the image quality of bio-based dye-printed silk.

Colon Drug Delivery Systems Based on Swellable and Microbially Degradable High-Methoxyl Pectin: Coating Process and In Vitro Performance.

Oral colon delivery systems based on a dual targeting strategy, harnessing time- and microbiota-dependent release mechanisms, were designed in the form of a drug-containing core, a swellable/biodegradable polysaccharide inner layer and a gastroresistant outer film. High-methoxyl pectin was employed as the functional coating polymer and was applied by spray-coating or powder-layering. Stratification of pectin powder required the use of low-viscosity hydroxypropyl methylcellulose in water solution as the binder. These coatings exhibited rough surfaces and higher thicknesses than the spray-coated ones. Using a finer powder fraction improved the process outcome, coating quality and inherent barrier properties in aqueous fluids. Pulsatile release profiles and reproducible lag phases of the pursued duration were obtained from systems manufactured by both techniques. This performance was confirmed by double-coated systems, provided with a Kollicoat® MAE outer film that yielded resistance in the acidic stage of the test. Moreover, HM pectin-based coatings manufactured by powder-layering, tested in the presence of bacteria from a Crohn's disease patient, showed earlier release, supporting the role of microbial degradation as a triggering mechanism at the target site. The overall results highlighted viable coating options and in vitro release characteristics, sparking new interest in naturally occurring pectin as a coating agent for oral colon delivery.

Multivariate Analysis and Computational Predictability of Modified Release Formulation of Chirally Pure Metoprolol Succinate

This study employs computational techniques to predict the performance of a modified-release matrix formulation of chirally pure S (-) Metoprolol Succinate, using a Quality by Design (QbD) approach. The research defines the Quality Target Product Profile (QTPP) and Critical Quality Attributes (CQAs) of the S (-) Metoprolol Succinate matrix formulation. To assess risks, an Ishikawa diagram and Failure Mode Effect Analysis (FMEA) following ICH Q8 guidelines were conducted. The formulation screening process utilized Plackett–Burman design, followed by optimization through Box–Behnken design. The modified-release formulation was developed using high shear granulation, incorporating a combination of high and low viscosity Hydroxypropyl Methylcellulose (HPMC) polymers along with other excipients. The impact of polymer composition and stearic acid on the release profile of S (-) Metoprolol Succinate was investigated, revealing their significant influence on the drug delivery system's desired effect. Specifically, the variables X1: HPMC K4M and X2: HPMC K100M were identified as key factors affecting drug release (Y1). Statistical analysis (ANOVA) confirmed the significance of the selected model, with predicted outcomes aligning well with observed results, comparable to the reference product Seleken® XL range. Both drug content and release performance were found to be similar to the innovator formulation. In summary, this investigation underscores the potential of employing a QbD approach with a combination of low and high viscosity HPMC polymers to achieve precise single-dose delivery of S (-) Metoprolol Succinate.

The Development of Super-Saturated Rebamipide Eye Drops for Enhanced Solubility, Stability, Patient Compliance, and Bioavailability

The present study aimed to develop clear aqueous rebamipide (REB) eye drops to enhance solubility, stability, patient compliance, and bioavailability. For the preparation of a super-saturated 1.5% REB solution, the pH-modification method using NaOH and a hydrophilic polymer was employed. Low-viscosity hydroxypropyl methylcellulose (HPMC 4.5cp) was selected and worked efficiently to suppress REB precipitation at 40 °C for 16 days. The additionally optimized eye drops formulation (F18 and F19) using aminocaproic acid and D-sorbitol as a buffering agent and an osmotic agent, respectively, demonstrated long-term physicochemical stability at 25 °C and 40 °C for 6 months. The hypotonicity (<230 mOsm) for F18 and F19 noticeably extended the stable period, since the pressure causing the REB precipitation was relieved compared to the isotonic. In the rat study, the optimized REB eye drops showed significantly long-lasting pharmacokinetic results, suggesting the possibility of reducing daily administration times and increasing patient compliance (0.50- and 0.83-times lower Cmax and 2.60- and 3.64-times higher exposure in the cornea and aqueous humor). In conclusion, the formulations suggested in the present study are promising candidates and offer enhanced solubility, stability, patient compliance, and bioavailability.

Formulation Optimization of Solid Dispersion of Candesartan Cilexetil

Context: Antihypertensive effects were achieved by quickly hydrolyzing candesartan cilexetil (CC), an inactive prodrug of candesartan, into active candesartan during absorption in the gastrointestinal tract. Due to its weak water solubility, CC has an inadequate intestinal absorption and a low oral bioavailability. Aim: The goal of this study was to make the medication CC more soluble in water. Materials and Methods: Low viscosity hydroxypropyl methylcellulose (HPMC) E5LV was used to prepare the solid dispersions through spray drying. Results: Study of dissolution, Fourier transform infrared spectroscopy, scanning electron microscopy (SEM), differential scanning calorimeter (DSC), and X-ray diffraction characterized the prepared solid dispersions. CC amorphized from its crystallized state, as shown by the findings from the SEM, DSC, and X-ray powder diffraction experiments. Comparing pure CC and solid dispersion, the dissolution rate was higher with the former. The surfactant and wetting property of HPMC E5LV slowed devitrification and had an anti-plasticization impact, increasing the solubility and stability of the solid dispersion. Conclusion: The final results indicated that the CC, a weakly water-soluble medication, dissolved much better in the solid dispersions.

In vitro and in vivo evaluation of a pH-, microbiota- and time-based oral delivery platform for colonic release

Several formulation strategies have been proposed for oral colon delivery, particularly for the therapy of inflammatory bowel disease (IBD). However, targeting the large intestine remains a challenging goal. The aim of this study was to develop and evaluate a novel type of drug delivery system, which is based on multiple drug release triggers for reliable performance. The system consists of: (i) a drug core, (ii) an inner swellable low-viscosity hydroxypropyl methylcellulose (HPMC) layer, and (iii) an outer film coating based on a Eudragit® S:high-methoxyl (HM) pectin (7:3 w/w) blend, optionally containing chitosan. Convex immediate release tablets (2 or 4 mm in diameter) containing paracetamol or 5-aminosalicylic acid (5-ASA) were coated in a fluid bed. The double-coated tablets exhibited pulsatile release profiles when changing the release medium from 0.1 N HCl to phosphate buffer pH 7.4. Also, drug release was faster in simulated colonic fluid (SCF) in the presence of fecal bacteria from IBD patients compared to control culture medium from tablets with outer Eudragit® S: HM pectin: chitosan coatings. The latter systems showed promising results in the control of the progression of colitis and alteration of the microbiota in a preliminary rat study.

Trace-level quantification of ethylene oxide and 2-chloroethanol in low-viscosity hydroxypropyl methylcellulose with solid phase microextraction and GC-MS

Ethylene oxide (EtO) is naturally present in numerous food products but recently EtO and its degradation product of 2-chloroethanol (2-CE) have been reported in amounts exceeding the maximum residue limit in Europe. The reports include hard capsules for dietary supplements made from low viscous hydroxypropyl methylcellulose (HPMC). The European council (EC) has proposed a generalized method for spices, seeds, and capsules utilizing QuEChERS, solid phase extraction (SPE), and GC-MS/MS to accommodate the need for analyte specificity, trace-level analysis, and higher throughput. HPMC has unique solvation properties and, without care, can potentially be transferred to the instrument. The current work presents the development of two methods specific for EtO and 2-CE in low viscous HPMC using solid phase microextraction (SPME) and GC-MS. Method optimization for solvation, SPME settings, and GC-MS settings are presented along with validation based on standard addition. Both methods present a high degree of specificity and limits of detection (EtO 6.7 µg/kg and 2-CE 12 µg/kg), comparable to those obtained with the EC method. Apart from sampling, the methods were fully automated and rely on low cost GC-MS instrumentation, widely available. Analyzed samples did not contain EtO or 2-CE, and method development was done with spiked samples. Contamination from plastic containers and analytical carry-over are shown as possible sources of EtO and 2-CE.

Drug-Polymers Composite Matrix Tablets: Effect of Hydroxypropyl Methylcellulose (HPMC) K-Series on Porosity, Compatibility, and Release Behavior of the Tablet Containing a BCS Class I Drug.

The purpose of this research was to see how the physicochemical properties and porosity of matrix tablets containing various types of hydroxypropyl methylcellulose (HPMC) K series affected the release of propranolol hydrochloride (PNL). PNL is a class I drug (high solubility and permeability) according to the Biopharmaceutics Classification System (BCS), making it an excellent model drug used for studying extended-release drug products. The direct compression method was used to prepare the HPMC-based matrix tablets. PNL and the excipients were found to be compatible using Fourier transform infrared spectroscopy (FTIR), powder X-ray diffraction (PXRD), and differential scanning calorimetry (DSC). The surfaces of all the compressed HPMC-based matrix tablets were rough, with accumulated particles and small holes. The compressed HPMC-based matrix tablet porosity was also determined by using mercury porosimetry. The compressed HPMC-based matrix tablets made of low viscosity HPMC had tiny pores (diameter < 0.01 μm). The shorter polymeric chains are more prone to deformation, resulting in a small pore proportion. The compressed HPMC-based matrix tablets sustained the release of PNL for over 12 h. The release exponent values (n), which reflect the release mechanism of the drug from the tablets, ranged from 0.476 to 0.497. These values indicated that the release was governed by anomalous transport. The compressed HPMC-based matrix tablets have the potential for a sustained release of PNL.

Oral colon delivery platform based on a novel combination approach: Design concept and preliminary evaluation

An oral colon delivery platform based on a novel combination strategy, leveraging multiple physiological characteristics of the intestine, is proposed. The system comprises a drug core, a water-swellable/soluble inner layer based on a hydrophilic cellulose derivative and an enteric outer layer (Eudragit® S) containing a microbially-degradable polysaccharide (high-amylose starch, Amylo N460), acting synergistically to prevent early release in the small intestine on the one hand, and release failure on the other. The Eudragit® S:Amylo N460 solid weight ratio in the external coating was 7:3; triethyl citrate and glyceryl monostearate were used as a plasticizer and an anti-tacking agent, respectively. The outer Eudragit® S/Amylo N460 layer was applied in a fluid bed using hydro-alcoholic or aqueous coating formulations. Two types of “inner” systems were studied: (i) Drug-loaded tablets coated with a low-viscosity hydroxypropyl methylcellulose (by aqueous spray-coating), and (ii) hydroxypropyl cellulose capsules prepared by injection-molding (filled with paracetamol as an analytical tracer). The obtained dosage forms were thoroughly characterized, including in vitro release measurements in various media. In all cases, pulsatile release profiles were obtained after medium change from 0.1 N HCl to phosphate buffer pH 7.4, with lag phases depending on the type and preparation technique of the hydrophilic polymer layer. The role of the microbiota on the release performance was explored in simulated colonic fluid (SCF), consisting in culture medium inoculated with fecal samples from inflammatory bowel disease patients. Clear differences in drug release were observed in SCF versus culture medium free of feces, indicating the effect of microbial degradation.

Evaluation of powder-layering vs. spray-coating techniques in the manufacturing of a swellable/erodible pulsatile delivery system

A swellable/erodible system for oral time-dependent release, demonstrated to provide consistent pulsatile and colonic delivery performance, has been manufactured through a range of coating techniques to achieve the functional hydroxypropyl methylcellulose (HPMC) layer. Although aqueous spray-coating has long been preferred, the processing times and yields still represent open issues, especially in view of the considerable amount of polymer required to give in vivo lag phases of proper duration. To make manufacturing of the delivery system more cost-efficient, different coating modes were thus evaluated, namely top and tangential spray-coating as well as powder-layering, using a fluid bed equipment. To this aim, disintegrating tablets of 5 mm in diameter, containing a tracer drug, were coated up to 50% weight gain with low-viscosity HPMC, either as a water solution or as a powder formulation. In all cases, process feasibility was assessed following setup of the operating conditions. Irrespective of the technique employed, the resulting dosage forms exhibited uniform coating layers able to defer the onset of release as a function of the amount of polymer applied. The structure and thickness of such layers differed depending on the deposition modes. With respect to top spray-, both tangential spray-coating and powder-layering were shown to remarkably ameliorate the process time, which was reduced to approximately 1/3 and 1/6, and to enhance the yield by almost 20 and 30%, respectively. Clear advantages associated with such techniques were thus highlighted, particularly with respect to powder-layering here newly proposed for application of a swellable hydrophilic cellulose derivative.

Study of controlled-release floating tablets of dipyridamole using the dry-coated method

Dipyridamole (DIP), having a short biological half-life, has a narrow absorption window and is primarily absorbed in the stomach. So, the purpose of this study was to prepare controlled-release floating (CRF) tablets of dipyridamole by the dry-coated method. The influence of agents with different viscosity, hydroxypropylmethylcellulose (HPMC) and polyvinylpyrollidon K30 (PVP K30) in the core tablet and low-viscosity HPMC and PVP K30 in the coating layer on drug release, were investigated. Then, a study with a three-factor, three-level orthogonal experimental design was used to optimize the formulation of the CRF tablets. After data processing, the optimized formulation was found to be: 80 mg HPMC K4M in the core tablet, 80 mg HPMC E15 in core tablet and 40 mg PVP K30 in the coating layer. Moreover, an in vitro buoyancy study showed that the optimized formulation had an excellent floating ability and could immediately float without a lag time and this lasted more than 12 h. Furthermore, an in vivo gamma scintigraphic study showed that the gastric residence time of the CRF tablet was about 8 h.

In vitro and in vivo evaluation of an oral multiple-unit formulation for colonic delivery of insulin

A multiple-unit formulation for time-dependent colonic release of insulin was obtained by coating insulin and sodium glycocholate immediate-release minitablets with: (i) Methocel® E50, a low-viscosity hydroxypropyl methylcellulose (inner coating), (ii) 5:1 w/w Eudragit® NE/Explotab® V17, a mixture of a neutral polymethacrylate with a pore-forming superdisintegrant (intermediate coating), and (iii) Aqoat® AS, enteric-soluble hydroxypropyl methylcellulose acetate succinate (outer coating). Sodium glycocholate was added as a permeation enhancer while the inner, intermediate and outer coatings were aimed, respectively, at delaying the onset of release through swelling/erosion processes, extending the duration of the lag phase by slowing down water penetration into the underlying functional layer, and overcoming variable gastric residence time. In vitro studies showed that neither insulin nor sodium glycocholate were released from the three-layer system during 2h of testing in 0.1N HCl, while complete release of the protein and of the enhancer occurred in phosphate buffer, pH 6.8, after consistent lag phases. No significant changes were noticed in the release profiles following twelve-month storage at 4°C. Oral administration of the novel formulation to diabetic rats elicited a peak in the plasma insulin concentration after 6h, which was associated with a sharp decrease in the glycemic levels. The relative bioavailability and pharmacological availability of such a formulation, as determined vs. the uncoated tablets, were 2.2 and 10.3, respectively. Based on these results, the three-layer system presented was considered a potentially interesting tool for oral colonic delivery of insulin and adjuvant compounds.

Hydroxypropyl methylcellulose, a viscous soluble fiber, reduces insulin resistance and decreases fatty liver in Zucker Diabetic Fatty rats

BackgroundDiets producing a high glycemic response result in exaggerated insulin secretion which induces hepatic lipogenesis, contributing to development of insulin resistance and fatty liver. Viscous dietary fibers blunt the postprandial rise in blood glucose, however their effect on type 2 diabetes and obesity are not entirely known. This study examined the effect of chronic consumption of the viscous, non-fermentable dietary fiber, hydroxypropyl methylcellulose (HPMC), on glucose control, insulin resistance and liver lipids in an obese diabetic rat model.MethodsThree groups of Zucker Diabetic Fatty (ZDF) rats were fed diets containing either 5% non-viscous cellulose (control), low viscosity HPMC (LV-HPMC) or high viscosity HPMC (HV- HPMC) for six weeks. Zucker lean littermates consuming cellulose served as a negative control. Markers of glucose control, including oral glucose tolerance test, glycated hemoglobin and urinary glucose, were measured as well as adiposity and the accumulation of liver lipids.ResultsThe HPMC diets increased the viscosity of the small intestinal contents and reduced the postprandial rise in blood glucose. The food efficiency ratio was greater with HPMC feeding compared to the obese control and urinary excretion of glucose and ketone bodies was reduced. The two HPMC groups had lower glycated hemoglobin and kidney weights and a reduced area under the curve during a glucose tolerance test, indicating improved glucose control. Epididymal fat pad weight as percent of body weight was reduced in the HV-HPMC group compared to the obese control group. The HV-HPMC group also had lower concentrations of liver lipid and cholesterol and reduced liver weight. However, HV-HPMC feeding did not affect hepatic gene expression of SREBP-1c or FAS. Muscle concentration of acylcarnitines, a lipid intermediate in fatty acid β-oxidation, was not different between the HPMC groups and obese control, suggesting no change in muscle fatty acid oxidation by HPMC.ConclusionsConsumption of the viscous non-fermentable fiber HPMC decreased diabetic wasting, improved glucose control and reduced insulin resistance and fatty liver in a model of obesity with diabetes.

Designing HPMC matrices with improved resistance to dissolved sugar

High concentrations of dissolved sugars can accelerate in vitro drug release in certain hydroxypropyl methylcellulose (HPMC) matrices ( Williams et al., 2009). This study investigated the potential for common formulation variables to modulate sucrose sensitivity, and explored if more resistant formulations could be designed. In a model matrix containing 30% HPMC (Methocel™ K4M), the inclusion of sugar as a tablet diluent was a key factor. Lactose:microcrystalline cellulose mixtures, dextrose and d-xylose all produced highly swollen, erodible matrices in 0.7 M sucrose (37 °C), which collapsed and rapidly released remaining drug after 1–4 h. This suggests internal and external sugars combine to disrupt the diffusion barrier properties of the gel layer. In contrast, matrices containing microcrystalline cellulose as the sole diluent provided extended release for 10 h. Small particle size (<63 μm) and high or low viscosity HPMC (Methocel™ K100M or K100LV) also improved sugar resistance. Knowledge of these variables allowed a significantly more resistant HPMC matrix to be designed which provided extended release for >16 h in 0.9 M sucrose. By judicious selection of excipient properties, the tolerance of HPMC matrices to high sucrose environments can be significantly improved.

Formulation of Nimesulide Floating Microparticles Using Low-viscosity Hydroxypropyl Methylcellulose

Purpose: To formulate prolonged-release floating microparticles that would minimise the irritant effect of weakly acidic drugs, such as nimesulide, on the stomach by avoiding direct contact with gastric mucosa. Methods: Sustained release floating microparticles of nimesulide was prepared by a coacervation (nonsolvent addition technique. Three different ratios of the coacervating polymer, low-viscosity hydroxypropyl methylcellulose (HPMC), were used, and the dissolution characteristics of the floating microparticles in simulated gastric and intestinal media were evaluated. In order to determine whether there was drug – polymer interaction, the microparticles were also assessed by infra-red (FTIR) spectroscopy and x-ray diffraction (XRD). Micromeritic properties of the microparticles were also assessed. Results: The drug content of the floating microparticles increased with increase in the level of HPMC incorporated. All floating microparticles formulations showed good flow properties while particle size analysis revealed that the appearance and size distribution of the formulations varied with polymer concentration. FTIR and XRD data indicated the crystalline nature of the drug but there was no chemical interaction between the drug and the polymer in the microparticles. Nimesulide release was faster in simulated intestinal fluid (pH 6.8) than in simulated gastric fluid (pH 1.2) and distilled water (pH 6.5). Conclusion: Coacervation non-solvent addition is a suitable technique for preparing floating microparticles of nimesulide using low-viscosity HPMC.Keywords: Floating microparticles, Nimesulide, HPMC, Coacervation, Non-solvent addition, Sustained release.

Viscous dietary fibers reduce visceral adiposity, lower oxidative stress and improve glucose control in ZDF rats

Viscous dietary fibers have been shown to blunt the postprandial rise in blood glucose. Previous studies in this lab have suggested that viscous dietary fibers decrease adiposity in rats with little or no change in body weight. The aim of this study was to examine the effect of consumption of viscous dietary fibers, hydroxypropyl methylcellulose (HPMC) and β‐glucans (Sustagrain), in an obese diabetic rat model. Zucker Diabetic Fatty (ZDF) rats and their lean counterparts (n=12) were fed diets containing either 5% non‐viscous cellulose, low viscosity (LV) HPMC, high viscosity (HV) HPMC or 40% Sustagrain flour. After 6 weeks of feeding, the HV HPMC group had a reduced percentage epididymal fat pad weight (visceral fat) compared to the other ZDF groups, but no differences in percentage inguinal (subcutaneous) fat pad weights were found. Fasting plasma leptin did not differ among the ZDF groups. Rats fed HPMC and Sustagrain had lower percent glycated hemoglobin and kidney weights than the cellulose group, indicating improved glycemic control. Urinary 8‐isoprostane concentrations in the ZDF cellulose, LV HPMC and Sustagrain groups were significantly higher than the lean group, but HV HPMC and lean groups did not differ. These results indicate that consumption of viscous dietary fiber can lower visceral adiposity and oxidative stress and improve diabetic control in ZDF rats. (Supported by the MN Agric Exp Station)Grant Funding Source: MN Agric Exp Station/CHE Administative Fund

Impact of phase separation of whey proteins/hydroxypropylmethylcellulose mixtures on gelation dynamics and gels properties

This work constitutes a study of the impact of phase separation behaviour on the gels properties of a low viscosity hydroxypropylmethylcellulose and whey protein concentrate (WPC) mixed system. The phase separation was characterized by drawing the limit of thermodynamic compatibility, i.e. binodal curve, at pH 6.5 and room temperature (25 °C). Gelling properties were studied under thermodynamic compatibility (WPC 12% (w/w)/E50LV 0.25% (w/w) mixed system) and incompatibility conditions (WPC 12% (w/w)/E50LV 4% (w/w) and WPC 20% (w/w)/E50LV 4% (w/w) mixed systems) Under thermodynamic compatibility the WPC/E50LV mixed system shows gelling parameters similar to WPC. Confocal scanning laser microscopy (CSLM) micrographs showed a regular pattern of microdomains of proteins imbibed into E50LV matrix. Confocal microscopy of WPC/E50LV mixture under thermodynamic incompatibility offered details about the constitution of continuous and non-continuous phase and characteristics of non-continuous phase domains. Related to gelling parameters, the solid character upon heating was reinforced in mixed systems since they reflected the concentrating effect arising from phase separation. On the other hand, the solid character of gels upon cooling correlated with the component constituting the continuous phase, and the gelation temperature was similar to polysaccharide-rich phase predicted gelation temperature. Regarding to textural properties, the presence of the polysaccharide diminished the hardness of the mixed gels inducing less resistance to small and large deformation. WPC 20% (w/w)/E50LV 4% (w/w) mixed gel presented an interesting particulated macrostructure. This result would find application in food design and technology if the E50LV concentration is chosen to finely control the rate and extent of WPC aggregation-gelation-particulation. These results could be used in microparticulation or microencapsulation application of whey proteins.

Characterization and physical stability of fast-dissolving microparticles containing nifedipine

The suitability of a poly(sodium methacrylate, methyl methacrylate) (NaPMM), a novel mucoadhesive material, to prepare fast-dissolving microparticles containing nifedipine (NIF) in the range of 25–75% w/w was verified. Microparticles made of a low-viscosity hydroxypropylmethylcellulose (HPMC), were also prepared to compare the NIF release profile and bioadhesive properties. The release test was carried out in oversaturation conditions. The physical state of microparticles was also investigated. The formulation stability was evaluated over a 3-month period in long-term and accelerated conditions. The presence of amorphous NIF within freshly prepared microparticles was attributed to interactions between the drug and both polymers. NaPMM conferred to microparticles suitable mucoadhesive properties and significantly increased NIF dissolution rate in comparison to HPMC. Nevertheless, NIF apparent solubilities obtained by NaPMM microparticles were lower than those obtained by the HPMC set. After 3-month storage in the case of HPMC microparticles, NIF dissolution rate and supersaturation degree significantly decreased due to drug crystallization. As far as NaPMM microparticles are concerned, neither NIF dissolution rate nor apparent solubility significantly changed.

수성미세채널을 형성하는 서방성 매트릭스 장용정을 이용한 탐스로신의 방출제어

Tamsulosin has been frequently used for the treatment of benign prostatic hyperplasia. To avoid dose-dependent side effects of tamsulosin upon oral administration, the development of sustained-release delivery system is required, that can maintain therapeutic drug levels for a longer period of time. The aim of this study was therefore to formulate sustained-release tamsulosin matrix tablets and assess their formulation variables. We designed enteric coated sustained-release tamsulosin matrices to fulfill above statement. Aqueous microchannels in the enteric film need to be formed in order to obtain tamsulosin release even in an acidic environment such as gastric region. In the sustained-release tamsulosin matrix, low viscosity hydroxypropylmethylcellulose was used as a rate controller. Povidone K30 was also added to the matrices to facilitate water uptake so that a decrease in the release rate of tamsulosin as time elapses was prevented, possibly leading to pseudo zero-order release of the drug. The matrices were enteric-coated with hydroxypropylmethylcellulose phthalate (HPMCP), along with povidone K30 as an aqueous microchannel former. With the aqueous microchannels formed within the enteric film, tamsulosin could be released in an acidic condition. The release of tamsulosin decreased with increasing thickness of HPMCP membrane while the release rates of tamsulosin from those having different HPMCP thickness in pH 7.2 aqueous media were not considerably different, indicating that the enteric film was promptly dissolved at pH 7.2. These results clearly suggest that the sustained-release oral delivery system for tamsulosin could be designed with satisfying drug release profile approved by the KFDA.

Rapid authentication of ginseng species using microchip electrophoresis with laser-induced fluorescence detection

Ginseng is one of the most expensive Chinese herbal medicines and the effectiveness of ginseng depends strongly on its botanical sources and the use of different parts of the plants. In this study, a microchip electrophoresis method coupled with the polymerase chain reaction (PCR)-short tandem repeats (STR) technique was developed for rapid authentication of ginseng species. A low viscosity hydroxypropyl methylcellulose (HPMC) solution was used as the sieving matrix for separation of the amplified STR fragments. The allele sizing of the amplified PCR products could be detected within 240 s or less. Good reproducibility and accuracy of the fragment size were obtained with the relative standard deviation for the allele sizes less than 1.0% (n=11). At two microsatellite loci (CT 12, CA 33), American ginseng had a different allele pattern on the electropherograms compared with that of the Oriental ginseng. Moreover, cultivated and wild American ginseng can be distinguished on the basis of allele sizing. This work establishes the feasibility of fast genetic authentication of ginseng species by use of microchip electrophoresis.